368 related articles for article (PubMed ID: 36395147)
41. Could ecosystem management provide a new framework for Alzheimer's disease?
Hubin E; Vanschoenwinkel B; Broersen K; De Deyn PP; Koedam N; van Nuland NA; Pauwels K
Alzheimers Dement; 2016 Jan; 12(1):65-74.e1. PubMed ID: 26341147
[TBL] [Abstract][Full Text] [Related]
42. Beta A4 protein deposition in familial Alzheimer's disease with the mutation in codon 717 of the beta A4 amyloid precursor protein gene and sporadic Alzheimer's disease.
Cairns NJ; Chadwick A; Lantos PL; Levy R; Rossor MN
Neurosci Lett; 1993 Jan; 149(2):137-40. PubMed ID: 8474686
[TBL] [Abstract][Full Text] [Related]
43. Loss of LR11/SORLA enhances early pathology in a mouse model of amyloidosis: evidence for a proximal role in Alzheimer's disease.
Dodson SE; Andersen OM; Karmali V; Fritz JJ; Cheng D; Peng J; Levey AI; Willnow TE; Lah JJ
J Neurosci; 2008 Nov; 28(48):12877-86. PubMed ID: 19036982
[TBL] [Abstract][Full Text] [Related]
44. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
[TBL] [Abstract][Full Text] [Related]
45. Protective roles of melatonin against the amyloid-dependent development of Alzheimer's disease: A critical review.
Vincent B
Pharmacol Res; 2018 Aug; 134():223-237. PubMed ID: 29981776
[TBL] [Abstract][Full Text] [Related]
46. Theranostic F-SLOH mitigates Alzheimer's disease pathology involving TFEB and ameliorates cognitive functions in Alzheimer's disease models.
Iyaswamy A; Wang X; Krishnamoorthi S; Kaliamoorthy V; Sreenivasmurthy SG; Kumar Durairajan SS; Song JX; Tong BC; Zhu Z; Su CF; Liu J; Cheung KH; Lu JH; Tan JQ; Li HW; Wong MS; Li M
Redox Biol; 2022 May; 51():102280. PubMed ID: 35286997
[TBL] [Abstract][Full Text] [Related]
47. Sigma ligands as potent inhibitors of Aβ and AβOs in neurons and promising therapeutic agents of Alzheimer's disease.
Ma WH; Chen AF; Xie XY; Huang YS
Neuropharmacology; 2021 Jun; 190():108342. PubMed ID: 33045243
[TBL] [Abstract][Full Text] [Related]
48. Mitochondrial dysfunction and Alzheimer's disease.
Maruszak A; Żekanowski C
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):320-30. PubMed ID: 20624441
[TBL] [Abstract][Full Text] [Related]
49. Closing in on the amyloid cascade: recent insights into the cell biology of Alzheimer's disease.
Huse JT; Doms RW
Mol Neurobiol; 2000; 22(1-3):81-98. PubMed ID: 11414282
[TBL] [Abstract][Full Text] [Related]
50. Mechanisms of action of amyloid-beta and its precursor protein in neuronal cell death.
Leong YQ; Ng KY; Chye SM; Ling APK; Koh RY
Metab Brain Dis; 2020 Jan; 35(1):11-30. PubMed ID: 31811496
[TBL] [Abstract][Full Text] [Related]
51. The impact of cholesterol, DHA, and sphingolipids on Alzheimer's disease.
Grimm MO; Zimmer VC; Lehmann J; Grimm HS; Hartmann T
Biomed Res Int; 2013; 2013():814390. PubMed ID: 24575399
[TBL] [Abstract][Full Text] [Related]
52. Remodeling Alzheimer-amyloidosis models by seeding.
Ulm BS; Borchelt DR; Moore BD
Mol Neurodegener; 2021 Feb; 16(1):8. PubMed ID: 33588898
[TBL] [Abstract][Full Text] [Related]
53. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients.
Li R; Lindholm K; Yang LB; Yue X; Citron M; Yan R; Beach T; Sue L; Sabbagh M; Cai H; Wong P; Price D; Shen Y
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3632-7. PubMed ID: 14978286
[TBL] [Abstract][Full Text] [Related]
54. Understanding the Amyloid Hypothesis in Alzheimer's Disease.
Paroni G; Bisceglia P; Seripa D
J Alzheimers Dis; 2019; 68(2):493-510. PubMed ID: 30883346
[TBL] [Abstract][Full Text] [Related]
55. Polyphenols as therapeutic molecules in Alzheimer's disease through modulating amyloid pathways.
Lakey-Beitia J; Berrocal R; Rao KS; Durant AA
Mol Neurobiol; 2015 Apr; 51(2):466-79. PubMed ID: 24826916
[TBL] [Abstract][Full Text] [Related]
56. Beyond pathology: APP, brain development and Alzheimer's disease.
Soldano A; Hassan BA
Curr Opin Neurobiol; 2014 Aug; 27():61-7. PubMed ID: 24632309
[TBL] [Abstract][Full Text] [Related]
57. Homocysteine fibrillar assemblies display cross-talk with Alzheimer's disease β-amyloid polypeptide.
Sade Yazdi D; Laor Bar-Yosef D; Adsi H; Kreiser T; Sigal S; Bera S; Zaguri D; Shaham-Niv S; Oluwatoba DS; Levy D; Gartner M; Do TD; Frenkel D; Gazit E
Proc Natl Acad Sci U S A; 2021 Jun; 118(24):. PubMed ID: 34099562
[TBL] [Abstract][Full Text] [Related]
58. α-Lipoic Acid Has the Potential to Normalize Copper Metabolism, Which Is Dysregulated in Alzheimer's Disease.
Metsla K; Kirss S; Laks K; Sildnik G; Palgi M; Palumaa T; Tõugu V; Palumaa P
J Alzheimers Dis; 2022; 85(2):715-728. PubMed ID: 34864665
[TBL] [Abstract][Full Text] [Related]
59. βAPP Processing Drives Gradual Tau Pathology in an Age-Dependent Amyloid Rat Model of Alzheimer's Disease.
Audrain M; Souchet B; Alves S; Fol R; Viode A; Haddjeri A; Tada S; Orefice NS; Joséphine C; Bemelmans AP; Delzescaux T; Déglon N; Hantraye P; Akwa Y; Becher F; Billard JM; Potier B; Dutar P; Cartier N; Braudeau J
Cereb Cortex; 2018 Nov; 28(11):3976-3993. PubMed ID: 29048465
[TBL] [Abstract][Full Text] [Related]
60. Amyloid-β and Tau at the Crossroads of Alzheimer's Disease.
Gallardo G; Holtzman DM
Adv Exp Med Biol; 2019; 1184():187-203. PubMed ID: 32096039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
